Compounds > dacarbazine

dacarbazine and Hepatocellular Carcinoma

dacarbazine has been researched along with Hepatocellular Carcinoma in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19904 (50.00)18.7374
1990's0 (0.00)18.2507
2000's1 (12.50)29.6817
2010's3 (37.50)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Carilli, A; Pellini Ferreira, B; Vasquez, J1
Barrientos, A; Carazo, Á; Delgado, Á; López Viota, J; Muñoz-de-Rueda, P; Muñoz-Gámez, JA; Quiles-Perez, R; Ruiz-Extremera, Á; Salmerón, J; Sanjuán-Nuñez, L1
Dorsch-Vogel, K; Gabrielson, A; He, AR; Jha, R; Marshall, JL; Pishvaian, MJ; Smaglo, B; Tesfaye, AA; Wang, H1
Barraja, P; Basso, G; Brun, P; Cecconet, L; Cirrincione, G; Dall'Acqua, F; Diana, P; Leszl, A; Salvador, A; Viola, G1
Siegel, MM; Siegel, SE; Stanley, P; Weinblatt, ME; Weitzman, JJ1
Rosenberg, SA1
Bast, RC; Borsos, T; Greene, SL; Ohanian, SH; Rapp, HJ; Segerling, M; Zbar, B1
Beal, DD; Bryan, GT; Skibba, JL; Whitnable, KK1

Trials

1 trial(s) available for dacarbazine and Hepatocellular Carcinoma

ArticleYear
Phase II study of temozolomide and veliparib combination therapy for sorafenib-refractory advanced hepatocellular carcinoma.
    Cancer chemotherapy and pharmacology, 2015, Volume: 76, Issue:5

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Benzimidazoles; Carcinoma, Hepatocellular; Dacarbazine; Disease-Free Survival; DNA Methylation; DNA Repair; DNA, Neoplasm; Drug Resistance, Neoplasm; Fatigue; Female; Genes, BRCA1; Genes, BRCA2; Humans; Kaplan-Meier Estimate; Liver Neoplasms; Male; Middle Aged; Niacinamide; Phenylurea Compounds; Poly(ADP-ribose) Polymerase Inhibitors; Salvage Therapy; Sorafenib; Temozolomide; Treatment Failure

2015

Other Studies

7 other study(ies) available for dacarbazine and Hepatocellular Carcinoma

ArticleYear
Metastatic Hepatoid Carcinoma of the Pancreas: First Description of Treatment With Capecitabine and Temozolomide.
    The American journal of the medical sciences, 2017, Volume: 353, Issue:6

    Topics: Adult; Antimetabolites, Antineoplastic; Antineoplastic Agents, Alkylating; Biopsy; Capecitabine; Carcinoma, Hepatocellular; Dacarbazine; Glucagon; Glucagonoma; Humans; Jaundice; Liver; Male; Neoplasm Metastasis; Pancreatic Neoplasms; Prognosis; Temozolomide; Treatment Outcome

2017
Synergistic cytotoxicity of the poly (ADP-ribose) polymerase inhibitor ABT-888 and temozolomide in dual-drug targeted magnetic nanoparticles.
    Liver international : official journal of the International Association for the Study of the Liver, 2015, Volume: 35, Issue:4

    Topics: Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Benzimidazoles; Carcinoma, Hepatocellular; Chemistry, Pharmaceutical; Dacarbazine; DNA Damage; Dose-Response Relationship, Drug; Drug Carriers; Drug Combinations; Drug Synergism; G2 Phase Cell Cycle Checkpoints; Hep G2 Cells; Humans; Liver Neoplasms; Magnetite Nanoparticles; Membrane Potential, Mitochondrial; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Poly(ADP-ribose) Polymerases; Signal Transduction; Technology, Pharmaceutical; Temozolomide

2015
Pyrrolotetrazinones deazaanalogues of temozolomide induce apoptosis in Jurkat cell line: involvement of tubulin polymerization inhibition.
    Cancer chemotherapy and pharmacology, 2009, Volume: 64, Issue:6

    Topics: Animals; Antineoplastic Agents; Apoptosis; bcl-2-Associated X Protein; Carcinoma, Hepatocellular; Caspase 3; Cell Cycle; Cell Line, Tumor; Cell Membrane; Cell Proliferation; Cell Survival; Dacarbazine; Gene Expression; Humans; Jurkat Cells; Male; Membrane Potential, Mitochondrial; Mice; Mice, Inbred BALB C; Microtubules; Mitochondria; Phosphatidylserines; Poly(ADP-ribose) Polymerases; Proto-Oncogene Proteins c-bcl-2; Reactive Oxygen Species; Temozolomide; Tubulin; Tubulin Modulators

2009
Preoperative chemotherapy for unresectable primary hepatic malignancies in children.
    Cancer, 1982, Sep-15, Volume: 50, Issue:6

    Topics: Adolescent; Antineoplastic Agents; Carcinoma, Hepatocellular; Child; Child, Preschool; Cyclophosphamide; Dacarbazine; Dactinomycin; Doxorubicin; Drug Therapy, Combination; Female; Fluorouracil; Follow-Up Studies; Humans; Infant; Liver Neoplasms; Male; Vincristine

1982
Future prospects for immunotherapy.
    Cancer, 1975, Volume: 36, Issue:2

    Topics: Animals; BCG Vaccine; Carcinoma, Hepatocellular; Dacarbazine; Guinea Pigs; Humans; Immunotherapy; Leukemia, Myeloid; Leukemia, Myeloid, Acute; Liver Neoplasms; Melanoma; Methotrexate; Mice; Neoplasms; Neoplasms, Experimental; Sarcoma

1975
Regression of established tumors and induction of tumor immunity by intratumor chemotherapy.
    Journal of the National Cancer Institute, 1976, Volume: 56, Issue:4

    Topics: Animals; Antineoplastic Agents; Carcinoma, Hepatocellular; Carmustine; Dacarbazine; Dactinomycin; Doxorubicin; Drug Therapy, Combination; Fluorouracil; Graft Rejection; Guinea Pigs; Injections; Injections, Intraperitoneal; Liver Neoplasms; Melphalan; Mercaptopurine; Methotrexate; Mitomycins; Neoplasm Transplantation; Neoplasms, Experimental

1976
Effects of 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide and its metabolites on Novikoff hepatoma cells.
    Cancer research, 1976, Volume: 36, Issue:8

    Topics: Animals; Carcinoma, Hepatocellular; Cell Division; Cells, Cultured; Dacarbazine; Darkness; DNA, Neoplasm; Hypoxanthines; Imidazoles; Light; Liver Neoplasms; Neoplasm Proteins; Neoplasms, Experimental; RNA, Neoplasm; Triazenes

1976